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Introduction
RNA regulons have been proposed as a means by which eukary-
otic cells coordinate gene expression (Keene and Tenenbaum, 
2002; Keene and Lager, 2005). In contrast to prokaryotes, in 
which the coordinated regulation of genes is achieved by ge-
nomic organization, eukaryotes coordinate the regulation of 
subsets of mRNAs involved in the same biological processes at 
the posttranscriptional level by manipulating compositions and 
activities of discrete subsets of RNPs. It has been postulated 
that related RNA sequences termed untranslated sequence ele-
ments for regulation (USER) codes, which are similar to zip 
codes for RNA localization, are used for specifi  c association 
with a variety of regulatory proteins involved in different levels 
of posttranscriptional regulation (Keene and Lager, 2005). 
mRNA nuclear export is one level of control that could be coor-
dinated in this way. Initially, mRNA export was thought to be a 
general process by which all mRNAs were transported from the 
nucleus to the cytoplasm irregardless of sequence-specifi  c features. 
More recent fi  ndings indicate that mRNA export can be co-
ordinated with other events in RNA metabolism, particularly 
transcription and splicing, and, thus, that nuclear history of 
transcripts can modulate the cytoplasmic fate of targeted 
mRNAs (Hieronymus and Silver, 2003, 2004; Hieronymus 
et al., 2004; Keene and Lager, 2005). This way, nuclear export 
can be coordinated through compartmentalization via mRNP 
organization, coupling the coordinated export of functional 
classes of mRNAs with their functions in biological processes 
such as proliferation, differentiation, and development.
Studies with eukaryotic translation initiation factor eIF4E 
provide an example of a factor that differentially affects the ex-
pression of a subset of mRNAs. Although it associates with all 
transcripts through the common 5′ methyl-7-guanosine (m
7G) 
cap structure (Sonenberg and Gingras, 1998), many groups 
showed that eIF4E overexpression does not lead to global in-
creases in protein expression (Rousseau et al., 1996; Clemens 
and Bommer, 1999). In the cytoplasm, mRNAs deemed eIF4E 
sensitive have their protein levels modulated by eIF4E more so 
than other mRNAs. This sensitivity is attributed to the complex-
ity of the 5′ untranslated regions (UTRs) in these transcripts 
(Sonenberg and Gingras, 1998). Up to 68% of eIF4E is found in 
the nucleus in a broad variety of species ranging from yeast to 
humans (Cohen et al., 2001; Iborra et al., 2001). Here, eIF4E 
overexpression leads to the increased export of cyclin D1 but 
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his study demonstrates that the eukaryotic transla-
tion initiation factor eIF4E is a critical node in an 
RNA regulon that impacts nearly every stage of cell 
cycle progression. Speciﬁ   cally, eIF4E coordinately pro-
motes the messenger RNA (mRNA) export of several 
genes involved in the cell cycle. A common feature of 
these mRNAs is a structurally conserved,  50-nucleotide 
element in the 3′ untranslated region denoted as an eIF4E 
sensitivity element. This element is sufﬁ  cient for localiza-
tion of capped mRNAs to eIF4E nuclear bodies, formation 
of eIF4E-speciﬁ  c ribonucleoproteins in the nucleus, and 
eIF4E-dependent mRNA export. The roles of eIF4E in 
translation and mRNA export are distinct, as they rely on 
different mRNA elements. Furthermore, eIF4E-dependent 
mRNA export is independent of ongoing RNA or protein 
synthesis. Unlike the NXF1-mediated export of bulk 
mRNAs, eIF4E-dependent mRNA export is CRM1 depen-
dent. Finally, the growth-suppressive promyelocytic leuke-
mia protein (PML) inhibits this RNA regulon. These data 
provide novel perspectives into the proliferative and onco-
genic properties of eIF4E.
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not glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
mRNA (Rousseau et al., 1996; Topisirovic et al., 2002; Culjkovic 
et al., 2005). Specifi   c association of eIF4E with cyclin D1 
mRNA in the nucleus requires the m
7G cap and a small element 
in its 3′ UTR referred to as an eIF4E sensitivity element 
(4E-SE; Culjkovic et al., 2005).
Overexpression of eIF4E is correlated with oncogenic 
transformation in tissue culture, cancers in animal models, 
and poor prognosis in several human cancers (Sonenberg and 
Gingras, 1998; Topisirovic et al., 2003b). Several lines of evi-
dence suggest that the mRNA export function of eIF4E contrib-
utes to its oncogenic potential. For instance, cyclin D1 mRNA 
export is up-regulated in specifi  c subtypes of human leukemia 
(Topisirovic et al., 2003b). These specimens contain unusually 
high levels of eIF4E, the vast majority of which is located in the 
nucleus (Topisirovic et al., 2003b). Also, inhibitors of eIF4E-
dependent mRNA export, the promyelocytic leukemia protein 
(PML), and proline-rich homeodomain (PRH) bind eIF4E in 
the nucleus, inhibit eIF4E-dependent mRNA export, and inhibit 
eIF4E-mediated oncogenic transformation (Cohen et al., 2001; 
Topisirovic et al., 2003a; Culjkovic et al., 2005). Furthermore, 
mutagenesis studies link the activity of eIF4E in mRNA export 
to its ability to oncogenically transform cells (Cohen et al., 
2001; Culjkovic et al., 2005).
Although cyclin D1 plays a key role in the cell cycle that 
links eIF4E’s proliferative properties and its mRNA export 
function, it is possible that eIF4E coordinately alters the expres-
sion of some other growth-promoting mRNAs as well to drive 
its proliferative potential. This study shows that several mRNAs 
involved in cell cycle progression are also targets of eIF4E-
  dependent mRNA export and that the subsets of mRNAs regu-
lated at the level of eIF4E-dependent mRNA export are distinct 
from those that are preferentially translated in the cytoplasm. 
We identifi  ed an underlying USER code for the export of eIF4E-
sensitive transcripts. This code is required for the subnuclear 
distribution of these RNAs as well as for the formation of rele-
vant eIF4E RNPs. Interestingly, the 4E-SE USER code is a 
structurally conserved element rather than a sequence-based 
one. eIF4E-dependent mRNA export can be decoupled from 
translation. Finally, eIF4E-dependent mRNA export occurs 
via an alternative mRNA export pathway than bulk mRNA. 
These results provide the basis for a novel paradigm of eIF4E-
mediated tumorigenesis.
Results
eIF4E alters the mRNA transport 
of a wide variety of transcripts
eIF4E-dependent mRNA export is potentially a broadly based 
mechanism by which eIF4E controls gene expression and, 
thereby, modulates growth and proliferation. We sought to de-
termine whether mRNAs other than cyclin D1 might be regu-
lated in an eIF4E-dependent manner. Using nuclear lysates, we 
isolated mRNAs associated with endogenous eIF4E via immuno-
precipitation (IP) or with recombinant eIF4E using a GST pull 
down–based method (the SNAAP method of Trifi   llis et al. 
[1999]) and identifi  ed these by differential display. Given that 
many of the identifi  ed genes are involved in cell cycle progres-
sion, eIF4E-immunoprecipitated fractions were also tested for 
other genes known to be involved in these processes as well 
as for known growth-inhibitory mRNAs (Table I). All target 
identifi  cation was confi  rmed by eIF4E IP and quantitative or 
semiquantitative RT-PCR analysis (Fig. 1 A and Fig. S1 A, avail-
able at http://www.jcb.org/cgi/conent/full/jcb.200607020/DC1). 
Importantly, the list provided in Table I is not intended to be 
  totally inclusive but rather to represent a sampling of the target 
mRNA population because results from differential display data 
suggest that hundreds of mRNAs are likely regulated in this 
manner; in this study, we identifi  ed only a subset (Fig. S2).
Many of the mRNAs that physically associate with the 
nuclear fraction of eIF4E code for gene products that act in cell 
cycle progression and survival, which is consistent with the 
physiological functions associated with eIF4E (Table I). Impor-
tantly, eIF4E does not bind all mRNAs tested (Table I). For in-
stance, eIF4E does not associate with the mRNAs corresponding 
to negative regulators of growth such as PML or p53 or house-
keeping genes such as GAPDH, β-actin, or α-tubulin. Also, this 
specifi  city is not a simple refl  ection of the sensitivity of mRNAs 
for regulation at the translational level, as mRNAs sensitive 
only at the translation level (such as VEGF; Clemens and 
Bommer, 1999) are not associated with the nuclear fraction of 
eIF4E (Table I). It is important to note that mRNAs that were 
not found in the eIF4E-immunoprecipitated fractions were 
readily detected in our nuclear lysates (Table II and Fig. S1 A). 
Note that that the estimated effi  ciency of IP with anti-eIF4E 
mAb is up to 80%.
Because eIF4E associates with the m
7G cap of mRNAs, we 
examined whether this was required for the association of eIF4E 
with mRNAs in the nuclear fraction (Fig. 1 A). eIF4E was immuno-
precipitated from the nuclear fraction, and mRNAs were treated 
with excess m
7GpppG or an analogue that does not bind eIF4E 
(GpppG). All mRNAs tested associate with eIF4E in a cap-
  dependent manner (i.e., m
7GpppG competes for binding, whereas 
GpppG does not). These data indicate that the association of 
eIF4E with mRNAs in the nucleus is m
7G cap dependent.
Physical association of eIF4E with mRNAs 
is correlated with enhanced mRNA export
To test whether there is a correlation between the ability of 
eIF4E to associate with mRNAs in the nuclear fraction and the 
ability of eIF4E overexpression to enhance eIF4E-dependent 
mRNA export, the subcellular distribution of identifi  ed mRNAs 
as a function of eIF4E overexpression was analyzed (Table II 
and Fig. S1 B). U937 and NIH3T3 cells overexpressing eIF4E 
or appropriate mutants were fractionated, and mRNAs levels 
were monitored by real-time PCR or Northern analysis. eIF4E 
overexpression increases the amount of eIF4E-sensitive mRNAs 
in the cytoplasmic fraction versus vector controls (Table II and 
Fig. S1 B). Conversely, transcripts that did not associate with 
eIF4E in the nuclear fraction did not have their export altered by 
eIF4E overexpression (Table II and Fig. S1 B). As expected, the 
subcellular distribution of β-actin, GAPDH, U6snRNA, and 
tRNALys were unaffected (Table II and Fig. S1 B). There is no 
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eIF4E could not bind these mRNAs because of a mutation in its 
cap-binding site (W56A), the subcellular distribution of these 
mRNAs was not altered (Table II and Fig. S1 B). Furthermore, 
the dorsal surface mutant W73A, which does not act in trans-
lation but promotes cyclin D1 mRNA export (Sonenberg and 
Gingras, 1998; Topisirovic et al., 2002), also promotes the ex-
port of other eIF4E-sensitive mRNAs (Table II and Fig. S1 B). 
Thus, it is likely that all sensitive mRNAs will require the m
7G 
cap-binding activity of eIF4E but not W73 on the dorsal surface 
for their interaction with eIF4E in the nucleus. Importantly, a 
circular dichroism study indicates that both W73A and W56A 
mutants have structures indistinguishable from wild-type eIF4E 
(Kentsis et al., 2001).
One of the consequences of the eIF4E-dependent promo-
tion of mRNA export is increased availability of these mRNAs 
to the translation machinery, leading to increased protein levels. 
Thus, we examined whether protein levels for a subset of identi-
fi  ed genes are elevated by eIF4E. Consistent with enhanced 
mRNA export, the overexpression of wild-type eIF4E or the 
W73A mutant leads to increased protein levels of a subset of 
Table I. List of mRNAs that associate (or do not) with nuclear eIF4E
Target RNA Function/growth-promoting properties Translationally sensitive to eIF4E Data for interaction
RNAs associated with the nuclear fraction of eIF4E
Cyclin D1 
 (gi:  77628152)
G1/S cell cycle progression 
(Liang and Slingerland, 2003)
No 
(Rousseau et al., 1996)
Fig. 1 A
Cyclin E1 
 (gi:  17318558)
G1/S cell cycle progression 
(Liang and Slingerland, 2003)
ND Fig. 1 A
Cyclin A2 
 (gi:  16950653)
S/G2/M cell cycle progression 
(Liang and Slingerland, 2003)
ND Fig. S1
Cyclin B1 
 (gi:  34304372)
G2/M cell cycle progression 
(Liang and Slingerland, 2003)
Yes 
(Cao and Richter, 2002)
Fig. S1
ODC 
 (gi:  4505488)
Polyamine synthesis/tumor promoting 
(Pegg, 2006)
Yes 
(Clemens and Bommer, 1999)
Fig. 1 A
Pim-1 
 (gi:  31543400)
S/T kinase 
(Bachmann and Moroy, 2005)
Yes 
(Clemens and Bommer, 1999)
Fig. 1 A
Mdm2 
 (gi:  46488903)
Survival/apoptotic rescue 
(Liang and Slingerland, 2003)
ND Fig. S1
c-Myc 
 (gi:  71774082)
Facilitates G1/S progression and
  transcriptionally up-regulates eIF4E 
(Liang and Slingerland, 2003; Schmidt, 2004)
Yes 
(Clemens and Bommer, 1999)
Fig. 1 A
Nibrin/NBS1 
 (gi:  67189763)
DNA repair/Akt activation/promotes growth 
(Chen et al., 2005)
ND Fig. S1
Fbox1 
 (gi:  16306583)
Promotes cell cycle progression 
(Liang and Slingerland, 2003)
ND Fig. S1
CGGbp1 
 (gi:  56550052)
Inﬂ  uences FMR1 expression 
(Naumann et al., 2004)
ND Fig. S1
P54nrb/NONO.1 
 (gi:  34932413)
RNA-binding protein/promotes survival 
(Stier et al., 2005)
ND Fig. S1
Selenoprotein S 
 (gi:  45439347)
Glucose-regulated ER protein 
(Gao et al., 2004)
ND Fig. S1
RNAs not associated with the nuclear fraction of eIF4E
GAPDH 
 (gi:  83641890)
Housekeeping/apoptotic No 
(Rousseau et al., 1996; 
Clemens and Bommer, 1999)
Fig. 1 A
VEGF 
 (gi:  71051577)
Mitogen/angiogenesis/tumor invasion 
(Roy et al., 2006)
Yes 
(Clemens and Bommer, 1999)
Fig. S1
p53 
 (gi:  8400737)
Proapoptotic/reduces eIF4E transcription 
(Zhu et al., 2005) 
No 
(Clemens and Bommer, 1999)
Fig. 1 A
β-Actin 
 (gi:  5016088)
Cytoskeletal No 
(Rousseau et al., 1996)
Fig. S1
α-Tubulin 
 (gi:  57013275)
Cytoskeletal No Fig.  S1
eIF4E 
 (gi:  54873625)
Translation and mRNA export 
  promotes growth and survival 
(Strudwick and Borden, 2002)
No 
(Clemens and Bommer, 1999; 
Strudwick and Borden, 2002)
Fig. 1 A
PML 
 (gi:  67089161)
Proapoptotic/G1 arrest 
(Borden, 2002)
No 
(Strudwick and Borden, 2002)
Fig. 1 A
α-Globin 
 (gi:  14456711)
Housekeeping No Fig. S1
c-ebpa 
 (gi:  28872793)
Arrests proliferation 
(Wang et al., 2001)
ND Fig. S1JCB • VOLUME 175 • NUMBER 3 • 2006  418
examined genes (Fig. 1 B and Fig. S1 D), whereas there is no 
increase in protein levels when the cap-binding mutant (W56A) 
is overexpressed. Importantly, wild-type eIF4E and the W73A and 
W56A mutants were expressed to similar levels (about threefold 
overexpression) for all experiments (Fig. 1 B and Fig. S1 D).
To determine whether these mRNAs are regulated through 
the same mechanism, it was important to examine the effect 
of PML. Our previous studies showed that PML colocalizes 
and coimmunoprecipitates with nuclear eIF4E and that this 
  interaction is important for the ability of PML to inhibit eIF4E-
dependent cyclin D1 mRNA export and eIF4E-mediated trans-
formation (Cohen et al., 2001; Topisirovic et al., 2002). Thus, 
we examined whether PML inhibits the export of a range of tar-
get mRNAs. In this way, we could determine whether PML was 
a general inhibitor of eIF4E-dependent export or whether these 
activities were limited to cyclin D1 mRNA. We observed de-
creased mRNA export (Fig. S1 B) and reduced protein levels of 
ornithine decarboxylase (ODC), c-myc, cyclin D1, and cyclin 
E1 (Fig. 1 C and Fig. S1 D) in cells overexpressing PML. Also, 
PML did not reduce levels of eIF4E, β-actin, or GAPDH pro-
teins (Fig. 1 C and Fig. S1 D), and there was no alteration in to-
tal mRNA levels for any of these transcripts when PML was 
overexpressed (Fig. S1 C). Thus, PML acts as an inhibitor of 
eIF4E-dependent mRNA export, not just as an inhibitor of cy-
clin D1 mRNA export.
In summary, the physical association of mRNAs with the 
nuclear fraction of eIF4E is strongly correlated with their en-
hanced nuclear export. In the cytoplasm, these mRNAs may 
(i.e., ODC) or may not (i.e., cyclin D1) be a subject of modula-
tion by eIF4E at the level of translation. Thus, eIF4E-mediated 
modulation at the nuclear level neither precludes nor necessi-
tates such modulation at the cytoplasmic level.
The RNA USER code for eIF4E-dependent 
mRNA export
Because we previously identifi  ed a 100-nucleotide 4E-SE in the 
3′ UTR of cyclin D1, which sensitizes cyclin D1 and corre-
sponding chimeric lacZ constructs to regulation by eIF4E at the 
mRNA export level (Culjkovic et al., 2005), we performed an 
extensive bioinformatics analysis to identify 4E-SE–like ele-
ments in the other target RNAs identifi  ed in Table I. Sequence 
analysis indicated that the 4E-SE was well conserved in cyclin 
D1 transcript (from birds to humans; Culjkovic et al., 2005), 
but a comparison of cyclin D1 with the other eIF4E-sensitive 
 transcripts  identifi  ed here failed to reveal any shared sequence 
homology. Therefore, we examined the possibility that the 
4E-SE is a structurally conserved element. Using the PatSearch 
algo  rithm (Grillo et al., 2003), we found that the cyclin D1 
4E-SE had a predicted pattern of stem loop pairs (SLPs). Using 
this same strategy, we found that Pim-1 also contained a similar 
Figure 1.  Enhanced mRNA export corresponds to elevated 
protein levels of eIF4E-sensitive targets. (A) Relative fold differ-
ence of mRNAs bound to nuclear eIF4E. mRNAs were immuno-
precipitated from untreated nuclear lysates or those treated 
with 50 μM m
7GpppG or GpppG. Values represent relative 
fold ± SD (error bars; normalized against untreated immuno-
precipitated IgG, which was set to 1). Calculations of fold 
were performed using the relative standard curve method 
(User Bulletin #2 ABI Prism 7700; Applied Biosystems). Rela-
tive amounts of the target mRNA = 10
[C (t)-b]/a were deter-
mined for each PCR reaction. Average values ± SD were 
calculated for each set of triplicates. Average values obtained 
for the IPs (i.e., average relative amount of immunoprecipi-
tated target mRNA) were divided by values obtained for 5% 
nuclear input (i.e., average relative amount of target mRNA 
present in the 5% of the amount of nuclear extract used for IP). 
Obtained values ± SD (i.e., average IP/average 5% nuclear) 
were normalized by setting the untreated IgG IP value to 1. 
(B and C) eIF4E-enhanced mRNA transport leads to up-
  regulated protein levels of corresponding mRNAs. Total cell 
lysates from U937 (B) or NIH3T3 (C) cells transfected as indi-
cated were analyzed for protein content by Western methods. 
Note that in C, where human PML was overexpressed, the 
5E10 mAb PML antibody only recognizes the human PML, not 
the endogenous mouse PML.EIF4E MODULATES EXPORT OF STRUCTURALLY RELATED MRNAS • CULJKOVIC ET AL. 419
putative element in its 3′ UTR. As for the cyclin D1 4E-SE 
mapping (Culjkovic et al., 2005), we made the corresponding 
constructs of Pim-1–lacZ fusions and showed that one of these 
elements (Pim-1–p4E-SE; Fig. 2 C) was a functional 4E-SE 
(see next paragraph). Note that a construct derived from a simi-
lar element in Pim-1’s 3′ UTR (SLP) did not associate with 
eIF4E (Fig. 2 C).
To best identify the common structural elements in the 
target mRNAs, we decided to compare the cyclin D1 4E-SE 
with the 4E-SE from one of the newly identifi  ed target mRNAs, 
Pim-1. We mapped the 4E-SE from cyclin D1 and the 4E-SE 
from Pim-1 to a minimal  50-nucleotide region (Fig. 2 A). 
These minimal domains, when fused to heterologous lacZ 
mRNA, immunoprecipitate with eIF4E and have their mRNA 
export promoted by eIF4E (Fig. 2 C; Culjkovic et al., 2005). 
Thus, these are functional 4E-SEs. In summary, although there 
was no sequence homology observed, both elements contain 
putative SLPs as predicted by PatSearch.
We used nuclease digestion methods to determine whether 
these two functional 4E-SEs had conserved secondary struc-
tural features such as the predicted stem loops. Importantly, 
these studies revealed that both elements fold into similar sec-
ondary structures. We refer to this element as an adjacent SLP 
(Fig. 2, A and B; and Fig. S3 A, available at http://www.jcb.org/
cgi/content/full/jcb.200607020/DC1). Consistently, biophysical 
analysis indicates that Pim-1 and cyclin D1 4E-SEs have similar 
biophysical properties. For instance, circular dichroism analysis 
of thermal melting curves using purifi  ed RNA oligomers for cy-
clin D1 and Pim-1 4E-SEs revealed multiphase behavior con-
sistent with the presence of multiple structural elements with 
different melting temperatures (unpublished data). Thus, both 
Pim-1 and cyclin D1 4E-SEs have similar secondary structures, 
which is consist with two adjacent stem loop elements.
An initial problem we encountered in these studies is that 
the presence of stem loop elements is common in the 3′ UTRs 
of cyclin D1 and Pim-1. In cyclin D1 alone, the PatSearch pro-
gram (Grillo et al., 2003) predicts 10 potential SLPs, but our 
previous fi  ndings indicate that the only part of the cyclin D1 3′ 
UTR that can impart eIF4E sensitivity is the aforementioned 
4E-SE (Culjkovic et al., 2005). Similarly, the Pim-1 3′ UTR 
contains two predicted adjacent SLPs, whereas only one is a 
functional 4E-SE (Fig. 2 C). Thus, we compared the secondary 
structures of Pim-1 and cyclin D1 4E-SEs to determine features 
that would enable us to distinguish functional 4E-SEs from 
other SLPs. Visual inspection of the secondary structures reveal 
the conservation of a set of A and U nucleotides (UX2UX2A, 
highlighted in Fig. 2 A). Importantly, these patterns of nucleo-
tides were not found in any of the other SLPs found in cyclin D1 
or Pim-1 3′ UTRs. Thus, these are features that can be used to 
distinguish functional 4E-SEs from other elements that have the 
potential to fold into similar secondary structures.
Further bioinformatics analyses showed that the predicted 
SLP structure with the conserved pattern of nucleotides is also 
present in other eIF4E-sensitive targets identifi  ed here (Table I, 
top). Importantly, none of the mRNAs that are not eIF4E sensi-
tive contain SLPs with the conserved pattern of nucleotides 
found in the functional 4E-SEs. In summary, we have identifi  ed 
a structural motif consisting of two adjacent SLPs, which im-
part eIF4E sensitivity. Importantly, there exist in this motif 
sequence features of 4E-SEs that can be used to distinguish 
functional 4E-SEs from other paired stem loop structures.
The 4E-SE is sufﬁ  cient for localization 
with eIF4E nuclear bodies
To assess whether the 4E-SE acted as an RNA zip code for 
eIF4E nuclear bodies, lacZ chimeric constructs with either Pim-1 
or cyclin D1 4E-SE were expressed in U2OS cells. Both chi-
meric mRNAs colocalize with eIF4E nuclear bodies (Fig. 2 D). 
In the absence of the 4E-SE, no localization of lacZ transcripts 
to eIF4E nuclear bodies is observed (Fig. 2 D). Importantly, 
Table II. Cytoplasmic/nuclear ratio of different mRNAs in U937 cells overexpressing eIF4E wild type or mutants
mRNA MSCV vector control 4E wild type W73A W56A
Cyclin D1 1 ± 0.035 11.995 ± 0.860 11.450 ± 860 1.110 ± 0.036
Cyclin E1 1 ± 0.022 3.442 ± 0.05 3.172 ± 0.208 1.200 ± 0.015
Cyclin A2 1 ± 0.044 5.472 ± 0.580 7.736 ± 0.540 1.002 ± 0.058
Cyclin B1 1 ± 0.108 4.720 ± 0.750 4.073 ± 0.434 1.475 ± 0.122
ODC 1 ± 0.010 6.847 ± 0.373 7.138 ± 0.852 1.272 ± 0.018
Pim-1 1 ± 0.051 3.435 ± 0.194 3.391 ± 0.251 1.029 ± 0.029
Mdm2 1 ± 0.325 15.698 ± 0.160 15.097 ± 0.793 1.379 ± 0.014
c-Myc 1 ± 0.033 2.980 ± 0.233 2.857 ± 0.226 0.925 ± 0.042
Nibrin 1 ± 0.030 4.728 ± 0.145 4.958 ± 0.230 1.226 ± 0.024
F-box 1 1 ± 0.069 11.202 ± 0.866 10.713 ± 0.633 1.363 ± 0.062
Selenoprotein S 1 ± 0.072 14.520 ± 1.164 11.839 ± 0.257 1.193 ± 0.234
VEGF 1 ± 0.111 0.835 ± 0.063 0.980 ± 0.261 1.387 ± 0.022
β-Actin 1 ± 0.173 1.020 ± 0.238 1.220 ± 0.203 1.313 ± 0.180
p53 1 ± 0.016 0.892 ± 0.006 1.392 ± 0.230 0.994 ± 0.008
α-Globin 1 ± 0.379 0.861 ± 0.237 1.265 ± 0.232 1.275 ± 0.346
Cytoplasmic/nuclear values represent relative fold ± SD normalized to vector control (MSCV), which was set to 1. Average values ± SD were calculated for each 
set of triplicates. Average values of all analyzed mRNAs obtained for each fraction of each sample were divided by GAPDH mRNA values obtained for the same 
fraction/sample. After dividing cytoplasmic with nuclear values of each sample, obtained cytoplasmic/nuclear values ± SD were normalized by setting the MSCV 
vector control cytoplasmic/nuclear value to 1.JCB • VOLUME 175 • NUMBER 3 • 2006  420
lacZ–4E-SE does not associate with eIF4E bodies that contain 
the negative regulator PML. This is consistent with our previous 
studies showing that there are two classes of eIF4E nuclear 
  bodies: those that colocalize with PML and those that colocal-
ize with endogenous cyclin D1 mRNA (Cohen et al., 2001; 
Topisirovic et al., 2002; Culjkovic et al., 2005). Thus, endogenous 
cyclin D1 mRNAs colocalize with eIF4E nuclear bodies that do 
not contain PML (Culjkovic et al., 2005). In this way, lacZ–4E-
SE transcripts and endogenous mRNAs behave similarly.
These experiments demonstrate that the 4E-SE is suffi  -
cient to localize capped mRNAs into eIF4E nuclear bodies irre-
spective of the rest of the mRNA sequence. Moreover, the 
4E-SE from Pim-1 and cyclin D1 are functionally equivalent in 
terms of localization activity. Thus, the 4E-SE provides an RNA 
zip code for localization to eIF4E nuclear bodies.
The 4E-SE makes eIF4E-dependent 
complexes
To establish whether the 4E-SE functions simply as a local-
ization signal or whether it acts in the formation of eIF4E-
  dependent mRNPs, we performed electromobility shift assays 
(EMSAs). Studies were performed with both the lacZ–cyclin 
D1–4E-SE (c4E-SE) and the lacZ–Pim-1–4E-SE (p4E-SE) to 
ensure that the assembly of these complexes is dependent on 
the 4E-SE itself and not on features specifi  c to either 4E-SE. 
RNA probes were 
32P 3′ end labeled and m
7G capped. The ad-
dition of either mouse eIF4E with a 6-kD solubility tag (m4E) 
or untagged human eIF4E (h4E) led to the formation of slower 
migrating species for both lacZ–4E-SE constructs (Fig. 3, 
A and B). Importantly, the addition of nuclear lysates led to 
the formation of substantially higher molecular weight com-
plexes, indicating that proteins other than eIF4E are likely to 
be present. Complex sizes were approximately the same for 
both 4E-SE constructs. The addition of cold competitor 4E-SE 
RNAs led to a reduction in signal, which is consistent with the 
4E-SE element competing for the labeled 4E-SE–containing 
transcripts (Fig. 3 E). The addition of nuclear lysates to lacZ 
transcripts lacking the 4E-SE did not lead to the formation of 
these complexes (Fig. 3 B and Fig. S3 B). Although the addi-
tion of purifi  ed eIF4E to the nuclear lysate supplemented with 
Figure 2.  A common secondary structure for the 4E-
SE that acts as a zip code for eIF4E nuclear bodies. 
(A) Secondary structure for cyclin D1 4E-SE (c4E-SE) 
and Pim-1 4E-SE (p4E-SE) as determined by RNase map-
ping experiments. Conserved set of A and U nucleo-
tides (UX2UX2A) are highlighted in yellow. (B) A sam ple 
gel. (C, top) Only one of the two predicted SLPs from 
Pim-1 3′ UTR (p4E-SE) immunoprecipitates with eIF4E. 
(bottom) eIF4E promotes the export of lacZ mRNA 
that contains minimal p4E-SE. Cytoplasmic/nuclear 
(c/n) values represent relative fold ± SD (error bars) 
normalized to the lacZ control, which was set to 1. 
Calculations were performed as described in Table II. 
(D) Colocalization of lacZ–p4E-SE, lacZ–c4E-SE, or 
lacZ transcripts with PML and eIF4E protein was exam-
ined in U2OS cells transfected with lacZ/lacZ–4E-SE. 
LacZ mRNA was detected using in situ hybridization 
with a biotin-labeled nick-translated probe to lacZ 
(red). Cells were then immunostained using an eIF4E 
mAb conjugated directly to FITC (green) and PML 
mAb 5E10 (blue). Importantly, lacZ mRNAs contain-
ing the 4E-SE from either cyclin D1 or Pim-1 colocalize 
to eIF4E nuclear bodies (arrowheads). As we have 
shown previously for endogenous cyclin D1 mRNA, 
there are two populations of eIF4E nuclear bodies: 
those that colocalize with lacZ mRNA and those that 
colocalize with PML. Magniﬁ   cation was 100× and 
3× (for lacZ and c4ESE) or 4× (p4ESE) digital zoom. 
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4E-SE–containing transcripts led to a considerable increase in 
the amount of RNA undergoing the shift, it did not alter the 
position of the shift (Fig. 3 B).
To determine whether the 4E-SE complexes formed from 
nuclear lysates were dependent on eIF4E, EMSAs were per-
formed with nuclear lysates depleted of eIF4E via IP. We 
  estimated that lysates were at least 80% depleted of eIF4E 
  (unpublished data). Lysates immunodepleted of eIF4E did not 
produce high molecular weight complexes (Fig. 3 B). The addi-
tion of purifi  ed tagged eIF4E to immunodepleted lysates led to 
a partial restoration of the complex, which could be expected 
because only eIF4E but not other factors that were depleted dur-
ing the anti-eIF4E IP were reintroduced. Thus, eIF4E and asso-
ciated factors are required for the formation of these RNPs. 
In addition, an antibody to eIF4E leads to a super shift of com-
plexes formed from nuclear lysates (Fig. 3 B). Identical results 
are observed for lacZ–p4E-SE. Finally, a mutant that disrupts 
the fi  rst stem loop (G10C11G12 mutated to CAC; Fig. 2 A) in the 
p4E-SE is defective in complex formation (Fig. 3 C). Thus, the 
4E-SE element forms complexes that are dependent on eIF4E 
and on the structure of the 4E-SE.
To further characterize these complexes, lacZ–4E-SE 
constructs were UV cross-linked followed by RNase digestion 
and SDS gel electrophoresis (Fig. 3 D). As for the EMSA stud-
ies, transcripts were m
7G capped and 3′ end labeled, and the ef-
fects of addition of purifi  ed eIF4E or nuclear lysates to the size 
of cross-linked complexes was monitored. Because mRNAs 
were 3′ end labeled, binding of the cap only by purifi  ed eIF4E 
was not suffi  cient to protect the rest of the RNA from RNase 
digestion. The addition of the nuclear lysate leads to substan-
tial shifts in molecular weight. Importantly, the lacZ–c4E-SE 
and the lacZ–p4E-SE form complexes similar in size. Three 
discrete species between 75 and 90 kD are observed (Fig. 3 D, 
arrows). The same complexes are absent in eIF4E-depleted 
  nuclear lysate, indicating that these require eIF4E to form. Con-
sistently, treatment of the nuclear lysate with the m
7GpppG cap 
analogue (nuclear lysates + cap) also disrupts 75–90-kD range 
complexes. These species are absent from the lacZ controls, 
which lack the 4E-SE. A lower band at  64 kD is present in 
all of the experiments, likely indicating the formation of some 
general RNP not directly involved with eIF4E and the 4E-SE. 
In summary, we observe two types of complexes: those that can 
form in the absence of eIF4E and are cap and 4E-SE indepen-
dent (Fig. 3 D, asterisk) and the second type that depends on 
eIF4E, the m
7G cap, and a structurally intact 4E-SE. The UV 
cross-linking experiments together with the EMSA results in-
dicate that the 4E-SE acts both as a zip code localizing mRNAs 
to bodies (Fig. 2 D) and as a USER code for the eIF4E nuclear 
mRNP (Fig. 3).
eIF4E-dependent mRNA export 
is independent of ongoing protein 
or RNA synthesis
We examined the importance of new protein synthesis and tran-
scription for eIF4E-dependent mRNA export. To inhibit protein 
synthesis, cells were treated with 100 μg/ml cycloheximide for 
1 h. Under these conditions, eIF4E-dependent mRNA export of 
lacZ–c4E-SE is not altered (Fig. 4 A). Also, the export of en-
dogenous cyclin D1 mRNA was not modulated by cyclohexi-
mide treatment (unpublished data). Similarly, actinomycin D 
treatment (10 μg/ml) did not affect the export of these mRNAs 
(Fig. 4 A). Although cycloheximide treatment did not modify 
export, it is still possible that the 4E-SE could modulate poly-
somal loading in an eIF4E-dependent manner. Thus, we moni-
tored polysomal profi  les of lacZ as a function of the 4E-SE and 
of eIF4E overexpression. The profi  les of lacZ and lacZ–c4E-SE 
are indistinguishable and are not altered by eIF4E overexpres-
sion (unpublished data). This is consistent with the fi  nding 
that eIF4E overexpression does not change cyclin D1 mRNA 
polysomal loading (Rousseau et al., 1996). Given that eIF4E-
  dependent mRNA export is independent of ongoing protein 
synthesis and that the 4E-SE does not alter polysomal loading, 
the functions of eIF4E in mRNA export and translation appear 
to be decoupled.
We previously demonstrated that lacZ–c4E-SE transcripts 
did not have altered stability relative to lacZ transcripts using 
Figure 3.  The 4E-SE is required for the formation of eIF4E-dependent 
complexes. (A and B) EMSA analysis indicates that lacZ transcripts, which 
contain either the cyclin D1 4E-SE (c4E-SE) or the Pim-1 4E-SE (p4E-SE), 
formed high molecular weight complexes in the presence of nuclear lysates 
(N). LacZ transcripts (control) without the 4E-SE did not form these com-
plexes. The addition of puriﬁ   ed mouse eIF4E with a 6-kD solubility tag 
(m4E) or untagged human eIF4E (h4E) causes partial shifts relative to shifts 
observed with nuclear lysate. With nuclear lysates immunodepleted of 
eIF4E (dpl N), gel shifts were not observed. Complexes could be super-
shifted by an anti-eIF4E antibody (N + α4E). Arrows indicate protein–RNA 
complexes. (C) Mutation of Pim-1 4E-SE (p4E-SE) reduces the efﬁ  cacy of 
the gel shift. No molecular weight markers are shown, as A–C and E are 
native gels. (D) UV cross-linking experiments showed the formation of spe-
ciﬁ  c complexes in the 75–90-kD mass range (indicated by arrows). These 
complexes are speciﬁ  cally depleted in the presence of excess m
7GpppG 
cap (cap) or if lysates are immunodepleted of eIF4E (dpl N). Asterisks indi-
cate complexes that are cap and 4E-SE independent. (E) The addition of 
unlabeled p4E-SE ribooligonucleotide (cold probe) to the p4E-SE nuclear 
complexes indicates that this element can efﬁ  ciently compete for complex 
formation. All transcripts were capped and 3′ end labeled.JCB • VOLUME 175 • NUMBER 3 • 2006  422
actinomycin D over the course of several hours (Culjkovic 
et al., 2005). However, it is still possible that mRNA turnover 
could be substantially more rapid than several hours. Thus, we 
constructed lacZ and lacZ–4E-SE TetON-inducible cell lines 
and examined the stability of these mRNAs immediately upon 
doxycycline addition. The presence of the 4E-SE does not sub-
stantially alter the stability of the lacZ transcripts in either the 
short (minutes) or long term (hours; unpublished data).
eIF4E-dependent mRNA export pathway 
is saturated by excess 4E-SE
We reasoned that if the 4E-SE is required for export, the over-
expression of lacZ–c4E-SE or lacZ–p4E-SE should specifi  cally 
inhibit the export of other (endogenous) 4E-SE–containing 
mRNAs by competing for the 4E-SE–specifi  c export machinery 
(Fig. 4, B and C). Using our TetON-inducible lacZ, lacZ–p4E-
SE, or lacZ–c4E-SE constructs, we monitored the export of 
  chimeric mRNAs as a function of total mRNA levels. The 
  expression of lacZ–p4E-SE and lacZ–c4E-SE mRNAs as a 
function of time is shown in Fig. 4 C. At early time points, when 
levels of lacZ mRNAs are low, 4E-SE export is more effi  cient 
with higher ratios of cytoplasmic to nuclear chimeric mRNAs. 
As the levels of these mRNAs increase, 4E-SE export becomes 
saturated, and the ratio of cytoplasmic to nuclear chimeric 
mRNAs decreases (Fig. 4 B). At the same time, the export of 
endogenous cyclin D1 mRNA was impaired by the expression 
of 4E-SE chimeric mRNAs (Fig. 4 B). Furthermore, the export 
of VEGF mRNA was not affected, which is consistent with its 
insensitivity to eIF4E at the mRNA export level (Fig. 4 B). 
Thus, the overexpression of 4E-SE leads to competition for the 
4E-SE–specifi  c export machinery.
4E-SE–mediated export is NXF1 
independent but CRM1 dependent
Because the best-described cellular mRNA export pathway in-
volves the NXF1/p15 heterodimer, which appears to mediate 
bulk mRNA export (Cullen, 2000, 2003a), the dependence of 
4E-SE mRNA export on NXF1 was examined (Fig. 5, A–C). 
Consistent with previous fi  ndings as well as our own, eIF4E 
does not immunoprecipitate with NXF1 in the nuclear fraction 
of cells (Lejeune et al., 2002; and unpublished data). However, 
this does not preclude an NXF1-dependent mechanism in which 
eIF4E does not need to physically associate with NXF1. To 
further investigate NXF1 involvement in 4E-SE export, Flag-
tagged NXF1- or NXF1/p15-overexpressing cells were im-
munoprecipitated with anti-Flag antibodies, and the presence 
of lacZ or lacZ–c4E-SE mRNAs was monitored by real-time 
PCR (Fig. 5 A). In contrast to lacZ mRNA that is enriched in 
the NXF1 fractions, lacZ–c4E-SE mRNA appears to be almost 
completely excluded. These results are independent of the pres-
ence or absence of p15 (unpublished data).
We extended these studies to examine the effects of knock-
ing down NXF1 expression on lacZ–c4E-SE export (Fig. 5 B). 
Overexpression of eIF4E enhanced the export of lacZ–c4E-SE 
transcripts even when NXF1 levels were substantially reduced, 
indicating that the export of lacZ–c4E-SE in the presence of 
overexpressed eIF4E is independent of NXF1. In the absence of 
the 4E-SE, the lacZ mRNA cytoplasmic/nuclear ratio was sub-
stantially reduced by NXF1 depletion. Analysis of lacZ protein 
levels confi  rmed the aforementioned fi  ndings (Fig. 5 C). As ex-
pected, siRNA treatment led to a reduction in NXF1 levels, 
whereas treatment with scrambled controls did not (Fig. 5 C). 
Furthermore, levels of eIF4G were not altered, which is consistent 
Figure 4.  Export of 4E-SE–containing mRNAs is independent of ongoing 
RNA and protein synthesis, and the pathway is saturated by excess 4E-SE. 
(A) Quantitative real-time PCR analysis of mRNA export of lacZ–c4E-SE and 
lacZ in eIF4E-overexpressing cells. Cytoplasmic/nuclear (c/n) ratios repre-
sent relative fold ± SD (error bars) normalized to the lacZ untreated control, 
which was set to 1. Calculations were performed as described in Table II. 
Treatments were 10 μg/ml actinomycin D for 1 h and 100 μg/ml cyclo-
heximide (CHX) for 1 h. (B and C) LacZ mRNA export was monitored as a 
function of both time and expression of lacZ transcripts ± 4E-SE induced 
with doxycycline. Expression as a function of time is shown. In parallel, the 
extent of export was monitored as the ratio of cytoplasmic/nuclear mRNA 
for each case. Solid lines represent trends in cells expressing lacZ–c4E-SE; 
dotted lines represent cells expressing lacZ–p4E-SE. Endogenous mRNAs 
from the same samples were also examined. Cyclin D1 mRNA export was 
reduced in cells expressing either lacZ–c4E-SE or lacZ–p4E-SE. Importantly, 
VEGF, which does not contain a 4E-SE, did not have its export affected in 
either case. Clearly, as the amount of 4E-SE–containing mRNAs increases 
in the cell (C), the ability to export these is reduced presumably because 
4E-SE–dependent export becomes saturated (B). Cytoplasmic/nuclear val-
ues represent relative fold ± SD normalized to lacZ only for each time point 
as described in Table II. For total RNAs, values represent relative fold ± SD 
normalized to the ﬁ  rst time point of induction for each transcript (4 h), which 
was set to 1. Average values of lacZ mRNA obtained for each time point 
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with a study showing that longer siRNA treatments (>72 h) are 
needed to reduce eIF4G levels (Herold et al., 2001). Thus, the 
export of 4E-SE–containing transcripts is independent of the 
NXF1 pathway. This does not rule out the possibility that a sub-
set of 4E-SE transcripts do transit through this pathway but sim-
ply that they do not require this pathway to be exported.
Because many RNAs can be exported through the CRM1 
pathway, we examined this possibility by using leptomycin B 
(LMB), a specific inhibitor of CRM1 (Cullen, 2003a,b). 
The export of lacZ or lacZ–c4E-SE mRNAs as a function of 
overexpressed eIF4E and LMB treatment was monitored us-
ing real-time PCR (Fig. 5 D). Strikingly, LMB suppressed the 
  export of lacZ–4E-SE constructs but not of lacZ or β-actin 
transcripts. LMB leads to the retention of 18S ribosomal RNA 
(rRNA; Fig. 5 D), which is consistent with previous studies 
showing that rRNA export requires CRM1 (Moy and Silver, 
1999, 2002).
Discussion
Novel export pathway involving eIF4E 
and 4E-SE–containing mRNAs
Since it was described, no underlying mechanism for eIF4E-
  dependent export has been determined (Rousseau et al., 1996). 
There are several characteristic features that differentiate eIF4E-
mediated export from the pathway used for bulk mRNA (sum-
marized in Fig. 6): (1) 4E-SE saturates export of the eIF4E 
pathway but does not affect the export of bulk mRNA (Fig. 4 B); 
(2) LMB inhibits eIF4E-dependent export (Fig. 5 D); and (3) 
the m
7G cap is required for the eIF4E pathway (Fig. 1 B and 
  Table II). Interestingly, there are many parallels between the eIF4E 
pathway and U small nuclear RNA (UsnRNA) export: both are 
CRM1 dependent, and both require the m
7G cap. However, in 
contrast to the eIF4E pathway, UsnRNA export depends on 
RNAs being cap-binding complex bound in complex to PHAX, 
which acts as an adaptor for CRM1 (Izaurralde et al., 1995; 
  Cullen, 2000, 2003a,b; Ishigaki et al., 2001).
In general, CRM1-mediated mRNA export requires co-
factors that depend on the type of RNA being exported (i.e., 
large rRNA, small rRNA, 5S rRNA, or UsnRNA; Cullen, 
2003a,b). Our previous studies indicate that eIF4E overexpres-
sion does not modulate the export of 18S or 28S rRNA, which 
is CRM1 dependent, or tRNA, which is exported using the 
  exportin-t receptor (Sarkar and Hopper, 1998; Topisirovic et al., 
2002, 2003a). Thus, we hypothesize that eIF4E or some subset 
of factors associated with the 4E-SE RNP require CRM1 
Figure 5.  eIF4E-dependent export is NXF1 independent and CRM1 
  dependent. (A) Comparison of lacZ mRNA in the NXF1 IP fractions. Cells 
were cotransfected with FlagNXF1/Flagp15 and lacZ or lacZ–c4E-SE. IPs 
were performed with anti-Flag antibody. LacZ/lacZ–c4E-SE mRNA was 
monitored by real-time PCR and normalized to IgG controls (as described 
in Fig. 1 A). (B) NXF1 siRNA treatment (72 h) inhibits the export of lacZ but 
not lacZ–c4E-SE–containing mRNAs. The cytoplasmic/nuclear (C/N) ra-
tios of lacZ or lacZ–c4E-SE mRNAs in cells overexpressing eIF4E as a func-
tion of siRNA treatment are shown. LacZ mRNA levels were normalized to 
18S rRNA, whose cytoplasmic/nuclear ratio is unaffected by NXF1 siRNA. 
(C) Western blot (WB) analysis indicates that NXF1 protein levels are re-
duced by siRNA treatment but not by scrambled controls (DS (-control)). 
A Western blot for eIF4G is shown as a negative control. LacZ protein levels 
correspond to alterations in mRNA export shown in B. (D) Dependence of 
c4E-SE export on leptomycin B (LMB). The cytoplasmic/nuclear ratio of 
lacZ–c4E-SE mRNA in eIF4E-overexpressing U2OS cells indicated that 4E-
SE export was sensitive to LMB (10 ng/ml for 4 h), whereas lacZ was not 
sensitive. 18S rRNA export was inhibited by LMB as expected, and β-actin 
mRNA export was consistently not affected. All RNAs were normalized to 
GAPDH mRNA (as described in Table II). (B and D) Cytoplasmic/nuclear 
lysate values represent relative fold ± SD (error bars) normalized to the 
lacZ untreated control, which was set to 1.
Figure 6.  Schematic representation of mechanisms for the export of 
  different classes of RNA. Overviews of characteristic features delineating 
the export of mRNAs via CRM1 or NXF1/p15 pathways are shown 
  together with features of the eIF4E-mediated export of mRNAs.JCB • VOLUME 175 • NUMBER 3 • 2006  424
  adaptor proteins specifi  c to the eIF4E-dependent pathway. 
Furthermore, these adaptors are found in limiting amounts and 
are titratable by high 4E-SE levels or by immunodepletion of 
eIF4E. Identifying such adaptor proteins will be an area of 
  intense future work.
A conundrum in understanding eIF4E-dependent mRNA 
export results from the observation that eIF4E stimulates the 
export of mRNAs that can be still exported under physiological 
eIF4E levels. Thus, eIF4E-dependent mRNA export is a means 
by which the cell rapidly up-regulates gene expression by stim-
ulating the export of mRNAs that can be exported through 
other pathways, albeit less effi  ciently. When eIF4E levels are 
low, or in the absence of the m
7G cap or 4E-SE, transcripts are 
exported (presumably) through the NXF1 pathway. This idea is 
consistent with previous suggestions that the NXF1 pathway is 
a default RNA export pathway for those RNAs that do not have 
any special features associated with them (Cullen, 2003b). In 
this way, eIF4E levels can act as a cellular rheostat. As levels 
increase, eIF4E-sensitive mRNAs are exported much more ef-
fi  ciently and in a coordinated fashion through the eIF4E-
  dependent CRM1-sensitive pathway described in this study. A 
recent study indicates that CRM1-dependent mRNA export can 
occur during T cell activation, indicating that external cellular 
signals can lead to alterations in mRNA export pathways 
(Schutz et al., 2006).
The role of eIF4E in 4E-SE–containing 
mRNA export and implications for cancer
The studies reported here suggest the possibility that the prolif-
erative and transforming properties associated with eIF4E are, 
at least partially, a result of the dysregulation of eIF4E- dependent 
mRNA export. These studies indicate a role for eIF4E in coor-
dinating the export and expression of transcripts involved in 
cell cycle progression, proliferation, and survival. Importantly, 
eIF4E does not promote the expression of negative regulators of 
itself (i.e., PML). eIF4E also promotes the expression of c-myc, 
a factor that up-regulates the transcription of eIF4E in some 
  cellular growth conditions (Schmidt, 2004). Thus, eIF4E modu-
lates the expression of many genes involved in multiple points 
of cell cycle progression.
The 4E-SE provides a USER code for targeting these tran-
scripts for export in an eIF4E-sensitive manner. Other tran-
scripts may be regulated by eIF4E at the translation level using 
USER codes that are different from the 4E-SE. Furthermore, 
the 4E-SE may associate with other, as yet unidentifi  ed, RNPs. 
In this way, the effects of eIF4E and regulation of 4E-SE–
  containing transcripts are likely to be complex and combinatorial. 
For instance, the translation of export-sensitive mRNAs does 
not depend on the 4E-SE but rather on the complexity of the 
5′ UTR. Transcripts such as Pim-1 and ODC (Rousseau et al., 
1996; Hoover et al., 1997) serve as examples of the combinato-
rial use of USER codes for modulating gene expression and 
support the idea of the use of such a network. Consistently, our 
experiments indicate that the translation and export functions of 
eIF4E can be decoupled based on the composition of the 3′ and 
5′ UTRs (i.e., eIF4E enhances the export of cyclin D1 but en-
hances the translation of VEGF).
Several key regulators of eIF4E-dependent mRNA export 
have been identifi  ed, including PML (Cohen et al., 2001) and 
several homeodomain proteins that contain conserved eIF4E-
binding sites (Topisirovic et al., 2003a, 2005). These regulators 
are positioned to modulate the entire RNA regulon, potently 
modulating cell cycle progression and cell survival. Our studies 
demonstrate that PML and PRH impede the eIF4E-dependent 
export of cyclin D1 and other 4E-SE–containing transcripts 
(Topisirovic et al., 2003a; Culjkovic et al., 2005; and this study). 
Further in vitro, PML can also inhibit eIF4E-sensitive transla-
tion (Kentsis et al., 2001) and, thus, is positioned to control the 
regulon at different levels. Stimulators of this growth regulon 
include HOXA9, which promotes both the mRNA export and 
translation of genes in the regulon (Topisirovic et al., 2005). 
The far-reaching activities of these regulators, particularly those 
that regulate multiple eIF4E functions simultaneously, likely lies 
in their ability to modulate eIF4E, a key nexus in this regulon. 
The physiological importance of this regulation is clear. In 
  primary specimens from acute myeloid leukemia patients, PRH 
is both down-regulated and delocalized from eIF4E nuclear 
bodies (Topisirovic et al., 2003b). At the same time, HOXA9 
is up-regulated and becomes associated with eIF4E in both 
the nuclear and cytoplasmic compartments, leading to the up-
regulation of both eIF4E-dependent mRNA export and translation 
(Topisirovic et al., 2005).
In conclusion, eIF4E-dependent modulation of mRNA 
export could provide an immediate response system by which 
the cell responds to extracellular stimuli before transcriptional 
reprogramming. Our results indicate that the modulation of 
mRNA export allows the coordinated modulation of cellular 
proliferation and provide one of the fi  rst examples of an RNA 
regulon that is positioned to directly impact human disease. The 
ability of eIF4E to modulate coordinated gene expression im-
pacting proliferation and cell survival pathways ensures maxi-
mum effi  ciency for its growth-promoting potential. Certainly, 
these fi  ndings do not preclude but rather complement critical 
modulation of gene expression by eIF4E at other levels of 
mRNA metabolism, particularly translation and mRNA stabil-
ity/sequestration. In summary, we defi  ne a novel mRNA export 
pathway that is used for the coordinate expression of genes that 
govern cell cycle progression and survival.
Materials and methods
Reagents and constructs
Chimeric constructs in pcDNA3.1lacZ vector (Invitrogen) were positioned 
3′ of the coding region of lacZ. Cyclin D1 minimal 4E-SE (c4E-SE) was 
ampliﬁ  ed using primers containing EcoRI or XbaI restriction sites at the 
5′ ends and the lacZ 3′ UTR construct as a template (Culjkovic et al., 
2005). The same approach was used for the cloning of Pim-1 constructs, 
in which pRBK–Pim-1 (a gift from N. Magnuson, Washington State 
University, Pullman, WA; Hoover et al., 1997) was used as a template. 
Primer sequences are given in Table S1 (available at http://www.jcb.
org/cgi/content/full/jcb.200607020/DC1). For the TetON system, 
chimeric lacZ constructs were cloned into pTREMyc vector (CLONTECH 
Laboratories, Inc.) using EcoRI and XbaI. pcDNA2Flag-eIF4E, pMV, pMV-
eIF4E wild type or mutants, pLINKSV40-PML, MSCV, MSCV-eIF4E wild 
type or mutants, and bacterial expression constructs were previously 
described (Cohen et al., 2001; Topisirovic et al., 2003b; Culjkovic et al., 
2005). Reagents used were all analytical grade from Sigma-Aldrich 
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Antibodies
Antibodies for immunoblotting were as follows: mAb anti-PML (5E10; 
  Stuurman et al., 1992), mAb anti-eIF4E (BD Biosciences), mAb anticyclin 
D1 (BD Biosciences), mAb anti-Xpress (Invitrogen), rabbit pAb anticyclin 
E1 (M20; Santa Cruz Biotechnology, Inc.), mAb anti-GAPDH (MAB374; 
Chemicon), mAb anti–c-myc (9E10; Santa Cruz Biotechnology, Inc.), rab-
bit pAb anticyclin A (C-19; Santa Cruz Biotechnology, Inc.), rabbit pAb 
antinibrin (Cell Signaling), mAb anti–Pim-1 (19F7; Santa Cruz Biotechnol-
ogy, Inc.), mAb cyclin B1 (GNS1; Santa Cruz Biotechnology, Inc.), mAb 
anti-eIF4G (BD Biosciences), and mAb anti-NXF1/TAP (BD Biosciences).
Cell culture and transfection
Stably eIF4E- and PML-transfected NIH3T3 and U937 cells were as de-
scribed previously (Topisirovic et al., 2002, 2003a). U937 cells were used 
to analyze endogenous Pim1, which is not expressed in NIH3T3 cells. 
LacZ/lacZ–4E-SE with or without 2Flag-eIF4E as well as the TetON lacZ 
system were stably transfected in U2OS cells. For NXF1 depletion, U2OS 
cells were transfected with LipofectAMINE 2000 and 10 nM siRNA duplex 
HSC.RNAI.N006362.1.3 (Integrated DNA Technologies) according to the 
manufacturer’s instructions. Cells were analyzed 72 h after transfection. 
Actinomycin D, cycloheximide, and LMB were all cell culture grade (Sigma-
Aldrich). Time and concentrations used in treatments are described in the 
Results and Figs. 4 and 5.
Immunopuriﬁ  cation of eIF4E and RT-PCR
Immunopuriﬁ  cation was performed as previously described (Culjkovic et al., 
2005). Real-time PCR analyses were performed using Sybr Green PCR 
Master mix (Applied Biosystems) in Mx3000P thermal cycler (Stratagene), 
and data were analyzed with MxPro software (Stratagene). All conditions 
were described previously (Culjkovic et al., 2005). Primer sequences are 
listed in Table S1. All calculations were performed using the relative stan-
dard curve method described in User Bulletin #2 (Applied Biosystems) and 
are more precisely described in the corresponding ﬁ  gure legends. Differen-
tial display of immunopuriﬁ  ed RNA was performed using the RNAimage 
kit (GeneHunter Corporation) according to the manufacturer’s instructions. 
The SNAAP protocol used for differential display was performed as de-
scribed previously (Triﬁ  llis et al., 1999), and Western blots were also per-
formed as described previously (Topisirovic et al., 2002, 2003a).
Cellular fractionation and Northern analysis
Fractionation and RNA isolation were performed as described previously 
(Lai and Borden, 2000; Topisirovic et al., 2002). Probes for U6 and 
tRNAlys for Northern blot analysis were previously described (Topisirovic 
et al., 2002).
Immunoﬂ  uorescence, in situ hybridization, and laser-scanning 
confocal microscopy
Experiments were performed as described previously (Cohen et al., 2001; 
Topisirovic et al., 2002). Fluorescence was observed using 100× optical 
magniﬁ  cation and 3 or 4× digital zoom as indicated on an inverted laser-
scanning confocal microscope (LSM510 META; Carl Zeiss MicroImaging, 
Inc.) exciting at 488, 543, or 405 nm (at RT). All channels were detected 
separately, and no cross talk between the channels was observed. The 
confocal micrographs represent a single optical section through the plane 
of the cell. Images were obtained using LSM510 software (Carl Zeiss 
  MicroImaging, Inc.) and were displayed using Photoshop CS 8.0 (Adobe). 
In situ hybridization was performed as previously described (Culjkovic 
et al., 2005) using nick-translated biotin-11-dUTP–labeled probes (Nick 
Translation kit; Roche). Probes were detected using Cy3-conjugated IgG 
fraction mouse mAb antibiotin (1:100; Jackson ImmunoResearch Laboratories). 
PML was detected using 5E10 mAb followed by Cy5-conjugated 
 donkey anti–mouse IgG (heavy and light chains; 1:100; Jackson Immuno-
Research Laboratories). eIF4E was detected using FITC-conjugated mouse 
mAb anti-eIF4E (BD Transduction Laboratories). Cells were mounted in 
Vectashield supplemented with DAPI (Vector Laboratories).
EMSA analyses were performed as previously described (Wein 
et al., 2003) with the following modiﬁ  cations: 20–50 μg of nuclear lysate 
were incubated with 
32P 3′ end–labeled lacZ, lacZ–c4E-SE, or lacZ–p4E-
SE transcript ( 50,000 cpm) in 25 μl NET-2 buffer supplemented with 
5 mg yeast tRNA (Sigma-Aldrich) and 3 mM MgCl2 for 30 min at RT with an 
additional 15 min after the addition of 2 mg/ml heparin. For competition 
studies, the unlabeled competitor RNAs were preincubated for 10 min with 
nuclear lysates before labeled RNAs were added. For supershift experi-
ments, nuclear lysates were preincubated with mAb anti-eIF4E (BD Biosci-
ences) for 15 min before the addition of labeled RNAs. Immunodepleted 
lysates were from IPs with rabbit pAb anti-eIF4E (Abcam). All mRNAs were 
in vitro transcribed using the mMessage mMachine T7 kit (Ambion) and 
were 3′ end labeled using [
32P]pCp and T4 RNA ligase (GE Healthcare). 
Samples were separated by electrophoresis on 5% native (19:1) polyacryl-
amide gels for 2 h at 250 V using 1× Tris-borate-EDTA buffer.
UV cross-linking
50 μg of nuclear lysates were incubated with radiolabeled probes (1–2 × 
10
5 cpm) using the same conditions as for the EMSA. After incubation with 
heparin, samples were placed on ice and UV irradiated for 15 min in a 
cross-linker (Stratalinker 1800 UV; Stratagene). Cross-linked RNA–protein 
complexes were treated with 10 U RNase A and 10 U RNase T1 for 15 min 
at 37°C. The reactions were stopped by the addition of 30 μl of 2× SDS 
sample buffer and heating 10 min at 95°C. Samples were loaded on 10 or 
12% SDS polyacrylamide gels and separated at 50 V for 16 h at RT.
RNase mapping
Analyses were performed as described previously (Clever et al., 1995) 
and according to the manufacturer’s instructions (Ambion). In brief,  0.5–
10
5 cpm 
32P 5′ end–labeled c4ESE or p4ESE RNA oligonucleotide probes 
(Integrated DNA Technologies) were mixed with 3 μg yeast tRNA and in-
cubated with 1, 0.1, or 0.01 U RNase V1 (Ambion) for 15 min at RT; 1, 
0.1, or 0.01 U RNase A (Ambion) for 5 min at RT; 1, 0.1, or 0.01 U 
RNase T1 (Sigma-Aldrich) for 15 min at RT; 1, 0.1, or 0.01 U RNase T2 
(Invitrogen) for 5 min at RT; or alkaline buffer for 1, 2, or 5 min at 95°C 
  (alkaline hydrolysis). For RNase digestions, denaturated RNA oligonucle-
otide probes (5 min at 75°C) were analyzed together with their native counter-
parts and used as an additional ladder control. Reactions were stopped by 
EtOH/NaAc precipitation. Samples were resolved on 6% polyacrylamide 
8 M urea gels in 1× Tris-borate-EDTA buffer.
Online supplemental material
Table S1 lists the PCR primers used in this study. Fig. S1 shows mRNAs regu-
lated by eIF4E in the nucleus. Fig. S2 shows differential display from RNAs 
immunoprecipitated with eIF4E mAb, mouse IgG as a negative control, and 
0.5% of input nuclear RNA from U2OS nuclear lysates. Fig. S3 shows that 
the secondary structure of Pim-1 4E-SE conﬁ  rmed by RNase mapping is nec-
essary for nuclear 4E RNP formation. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200607020/DC1.
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